Short answer
Public pharmacy data shows creatine as the fastest riser in Poland: sales roughly doubled from 2024 to 29,159 packs in 2025. Collagen reached 9.1 million packs and PLN 308 million in pharmacies in 2025. Magnesium sold 12 million packs in 2024, with value up nearly five-fold since 2015. Ashwagandha is popular but dose-restricted by the GIS supplement team.
Why ingredient trends in Poland are hard to read
There is no public, ingredient-level sales dataset for the whole Polish supplement market. What exists is a patchwork:
- Pharmacy panel data, published in pieces by providers such as OSOZ (Kamsoft). It is precise, but covers only pharmacies.
- Market research summaries from PMR, PIE and international houses, which name trend categories but rarely publish ingredient numbers.
- The GIS notification register, which shows what companies launch, not what consumers buy.
- Search and marketplace data, which shows interest, and sometimes only curiosity.
Each source has a blind spot. Creatine is mostly bought in sports shops and online, so pharmacy data understates it. Vitamin D is bought heavily in pharmacies, so pharmacy data describes it well. A credible trend call needs at least two independent signals pointing the same way. Below we go through the ingredients foreign brands ask us about most, and state only what a public source supports.
What the public data shows, ingredient by ingredient
| Ingredient | Public data point | Source | Our read |
|---|---|---|---|
| Creatine | 29,159 packs and PLN 1.16 million in pharmacies in 2025, about twice 2024. 113 products in 2025, 38 of them new within a year. Forecast up to 106,000 packs in 2026. | OSOZ, 2026 | Fastest relative growth. Pharmacy is a small, new channel for it. |
| Collagen | 9.1 million packs and PLN 308 million in pharmacies in 2025. Products up from 64 to 728 in ten years. | OSOZ, 2026 | Large and still growing, very crowded. |
| Magnesium | 12 million packs in 2024 versus a 12.7 million peak in 2022. Value up from PLN 69 million (2015) to PLN 342 million (2024). Forecast +5.5% in 2025. | OSOZ, 2025 | Mature volume, value growth driven by price and premium forms. |
| Vitamin D | 5.1 million packs in 2019, 9.9 million in 2021, a record projected 10.8 million in 2022. 38.3% of vitamin items on shopping lists in 2025. | OSOZ, 2022, Listonic, 2026 | Pandemic step-change, now a staple. |
| Ashwagandha | Named among trending ingredients in 2024-2025. Dose limits set by GIS team resolution 7/2020. | PIE via DI, 2025, IGI Food Law | Real demand, real regulatory risk. |
| Proteins and amino acids | Fastest-growing ingredient segment in Poland to 2030. | Grand View Research | Supports the creatine signal. |
| Probiotics, joint support | Among the fastest-growing segments named by PMR. | PMR via ŚPF, 2025 | Growth without public ingredient numbers. |
| Electrolytes | Named in the emerging GLP-1 companion category alongside protein and fibre. | Wiadomości Kosmetyczne, 2026 | No public Polish sales data we could verify. |
| Functional mushrooms | No public Polish sales or growth figures found. | None | Treat as a hypothesis, not a trend. |
Two notes on reading this table. Pharmacy pack counts measure units, not people, and prices move a lot: the average creatine pack in pharmacies went from about PLN 8 in 2018 to nearly PLN 40 in 2025 (OSOZ), and magnesium roughly doubled in price per pack between 2015-2017 and 2024 (OSOZ). Value growth can come from premiumisation alone.
The clear signals: creatine, collagen, magnesium, vitamin D
Creatine is the textbook new-wave ingredient. It has moved from gyms into mainstream wellness, and Polish pharmacies are following: sales roughly doubled from 2024 to 2025, and OSOZ forecasts a further jump in 2026. The product count tells the same story: 5 creatine supplements ten years ago, 113 in 2025 (OSOZ). Grand View's finding that proteins and amino acids are the fastest-growing ingredient segment points the same way. For a foreign brand this is the most open of the four, but the window is closing as local sports nutrition brands move into pharmacy and drugstore.
Collagen is big, not new. PLN 308 million in pharmacies alone in 2025 and more than 700 products (OSOZ). Growth continues, but entering with a plain collagen powder means competing on price with hundreds of listings. The opening, if any, is in format, source, dose transparency or a sharply defined audience.
Magnesium is the volume anchor of Polish supplementation. Pack volumes have been flat at around 12 million a year since 2022, while value keeps rising (OSOZ). That is a premiumisation market: consumers trade up to better-absorbed forms and combinations, which favours brands with a clear quality story and a correct % NRV presentation.
Vitamin D went through a pandemic step-change, from 5.1 million pharmacy packs in 2019 to around 10 million in 2021-2022 (OSOZ), and is now the most-listed vitamin on Polish shopping lists (Listonic via Wiadomości Kosmetyczne). It is a staple, bought seasonally and on promotion. Growth now comes from formats and combinations, not from new users.
The watchlist: ashwagandha, electrolytes, mushrooms, GLP-1 companions
Ashwagandha appears in every Polish trend round-up we have read, including the PIE-based summary in Dziennik Internautów and consumer research in Świat Przemysłu Farmaceutycznego. The regulatory picture is what makes it tricky. The GIS supplement team's resolution 7/2020 accepts powdered root below 3 g a day, caps withanolides at 10 mg per daily portion and recommends warnings for pregnant and breastfeeding women, children and people on sedatives (IGI Food Law). Denmark banned ashwagandha in supplements in 2023, and other Nordic authorities have reviewed it (Farmer.pl, 2025). A high-dose, high-withanolide extract that sells in the US or UK may need reformulation for Poland.
Electrolytes and GLP-1 companion products (protein, fibre, micronutrients, gut and hair support) are appearing in Polish trade press as a new category (Wiadomości Kosmetyczne, 2026). We could not find public Polish sales data to size them. Claims are the constraint here: anything that links a supplement to a medicine or to weight loss outside an authorised health claim will draw attention.
Functional mushrooms such as lion's mane are visible in Polish e-commerce content, but we found no public figures on their growth in Poland. Before launching, check each species and extract type against the EU novel food catalogue. That check decides more about your launch than any trend report.
How we check a trend
Before we tell a brand that an ingredient is growing in Poland, it has to pass the same five checks. Any one signal on its own can mislead.
| Signal | What it tells you | Where we get it | The trap |
|---|---|---|---|
| Search demand | Whether consumers are looking for the ingredient, and how seasonal it is | Search trend tools, marketplace search suggestions | Curiosity after a viral video looks like demand for a few weeks |
| GIS notifications | How many companies are launching with the ingredient, and how fast | The GIS register, cleaned by Wellmade Intelligence | Bulk personalised registrations are about 23% of the register. Composition is only filled from 2020 |
| Pharmacy sales | Units and value actually sold in pharmacies | Published pharmacy panel data such as OSOZ | Misses sports shops, drugstores and marketplaces |
| Marketplace and retail shelf | Number of offers, price bands, review velocity, bestseller positions | Allegro, drugstore and online pharmacy listings | Listings are cheap, many offers do not sell |
| Regulatory signals | Whether the ingredient can stay on the market at your dose | GIS team resolutions, EU novel food catalogue, other EU authorities | A ban elsewhere in the EU can arrive in Poland as a GIS letter |
An ingredient passes when search, notifications and at least one sales signal rise together over at least two seasons, and the regulatory check is clean at the dose you plan. Creatine passes today. Ashwagandha passes on demand and fails on dose for many foreign formulas. Mushrooms, in public data at least, do not yet pass.
One practical point on notifications: because composition data only exists from 2020, a naive query for "new products with ingredient X" undercounts everything launched earlier and makes older ingredients look newer than they are. We always compare like with like, from 2020 onward, with bulk registrations removed.
What this means for your launch
- Do not lead with the trend, lead with the gap. A growing ingredient with 700 products (collagen) is a harder entry than a mature one where the premium tier is thin (some magnesium forms).
- Check dose before demand. Poland applies national practice on doses of vitamins, minerals and botanicals. An ingredient that is trending but capped below your dose is a reformulation project, not a launch.
- Match the ingredient to the channel. Creatine and protein live online and in sports retail. Vitamin D and magnesium live in pharmacies and drugstores. Your channel plan follows from the ingredient.
- Keep claims inside the register. Most trend ingredients, especially botanicals, have no authorised health claims. Your Polish copy has to sell without them.
If you want your hero ingredients run through the five checks above for Poland, our market entry report includes that analysis.
Sources
- OSOZ / Kamsoft, creatine in pharmacies (July 2026)
- OSOZ / Kamsoft, pharmacy year 2025 and collagen (February 2026)
- OSOZ / Kamsoft, magnesium in pharmacies (January 2025)
- OSOZ / Kamsoft, vitamin D in pharmacies (December 2022)
- Wiadomości Kosmetyczne, Listonic shopping-list data (February 2026)
- Grand View Research, Poland Dietary Supplements Market
- Świat Przemysłu Farmaceutycznego, citing PMR (September 2025)
- Dziennik Internautów, citing PIE (January 2025)
- Świat Przemysłu Farmaceutycznego, consumer expectations (October 2025)
- IGI Food Law, ashwagandha status (November 2023)
- Farmer.pl, ashwagandha restrictions in the EU (September 2025)
- Wiadomości Kosmetyczne, GLP-1 companion products (August 2026)